Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer

We demonstrated that ER/PR expression remain prognostically relevant within the molecular subgroups, and that a three-tiered cutoff refines prognostication. These data support incorporating routine evaluation of ER/PR expression in clinical practice.